A citation-based method for searching scientific literature

Jessica E van der Aa, Jacob P Hoogendam, Els S F Butter, Margreet G E M Ausems, René H M Verheijen, Ronald P Zweemer. Fam Cancer 2015
Times Cited: 8







List of co-cited articles
34 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations.
Richard M Brohet, Maria E Velthuizen, Frans B L Hogervorst, Hanne E J Meijers-Heijboer, Caroline Seynaeve, Margriet J Collée, Senno Verhoef, Margreet G E M Ausems, Nicoline Hoogerbrugge, Christi J van Asperen,[...]. J Med Genet 2014
56
50

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
50

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.
B B J Hermsen, R I Olivier, R H M Verheijen, M van Beurden, J A de Hullu, L F Massuger, C W Burger, C T Brekelmans, M J Mourits, G H de Bock,[...]. Br J Cancer 2007
97
50

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
Dorina M van der Kolk, Geertruida H de Bock, Beike K Leegte, Michael Schaapveld, Marian J E Mourits, Jakob de Vries, Annemieke H van der Hout, Jan C Oosterwijk. Breast Cancer Res Treat 2010
116
37

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?
Nienke M van der Velde, Marian J E Mourits, Henriëtte J G Arts, Jacob de Vries, Beike K Leegte, Grieteke Dijkhuis, Jan C Oosterwijk, Geertruida H de Bock. Int J Cancer 2009
83
37



The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Joanna B Madalinska, Marc van Beurden, Eveline M A Bleiker, Heiddis B Valdimarsdottir, Judith Hollenstein, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2006
143
37

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
498
25

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
25

Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.
Paul A M Meeuwissen, Caroline Seynaeve, Cecile T M Brekelmans, Hanne J Meijers-Heijboer, Jan G M Klijn, Curt W Burger. Gynecol Oncol 2005
68
25

Model of care for women at increased risk of breast and ovarian cancer.
Geertruida H De Bock, Jan Willem Hesselink, Carriene Roorda, Jaap De Vries, Harry Hollema, Jan P C Jaspers, Theo Kok, Paul M N Werker, Jan C Oosterwijk, Marian J E Mourits. Maturitas 2012
13
25


Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers.
Claudia Marchetti, Francesca De Felice, Innocenza Palaia, Giorgia Perniola, Angela Musella, Daniela Musio, Ludovico Muzii, Vincenzo Tombolini, Pierluigi Benedetti Panici. BMC Womens Health 2014
89
25

Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.
B A M Heemskerk-Gerritsen, C Seynaeve, C J van Asperen, M G E M Ausems, J M Collée, H C van Doorn, E B Gomez Garcia, C M Kets, F E van Leeuwen, H E J Meijers-Heijboer,[...]. J Natl Cancer Inst 2015
119
25

Stopping ovarian cancer screening in BRCA1/2 mutation carriers: effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimens.
Catheleine M G van Driel, Geertruida H de Bock, Henriette J G Arts, Aisha S Sie, Harry Hollema, Jan C Oosterwijk, Marian J E Mourits. Maturitas 2015
13
25

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.
Angela R Bradbury, Comfort N Ibe, James J Dignam, Shelly A Cummings, Marion Verp, Melody A White, Grazia Artioli, Laura Dudlicek, Olufunmilayo I Olopade. Genet Med 2008
67
25


Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective.
E R Woodward, H V Sleightholme, A M Considine, S Williamson, J M McHugo, D G Cruger. BJOG 2007
63
25


Mindfulness training for coping with hot flashes: results of a randomized trial.
James Francis Carmody, Sybil Crawford, Elena Salmoirago-Blotcher, Katherine Leung, Linda Churchill, Nicholas Olendzki. Menopause 2011
82
25

Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial.
Caroline J Hoffman, Steven J Ersser, Jane B Hopkinson, Peter G Nicholls, Julia E Harrington, Peter W Thomas. J Clin Oncol 2012
165
25

Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial.
Julienne E Bower, Alexandra D Crosswell, Annette L Stanton, Catherine M Crespi, Diana Winston, Jesusa Arevalo, Jeffrey Ma, Steve W Cole, Patricia A Ganz. Cancer 2015
146
25

A cognitive model of menopausal hot flushes and night sweats.
Myra S Hunter, Eleanor Mann. J Psychosom Res 2010
86
25

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers.
D G Evans, K N Gaarenstroom, D Stirling, A Shenton, L Maehle, A Dørum, M Steel, F Lalloo, J Apold, M E Porteous,[...]. J Med Genet 2009
82
25

Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention.
Sharon L Bober, Christopher J Recklitis, Jennifer Bakan, Judy E Garber, Andrea F Patenaude. J Sex Med 2015
34
25

Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
A Benshushan, N Rojansky, M Chaviv, S Arbel-Alon, A Benmeir, T Imbar, A Brzezinski. Climacteric 2009
46
25


Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Joanna B Madalinska, Judith Hollenstein, Eveline Bleiker, Marc van Beurden, Heiddis B Valdimarsdottir, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2005
167
25


Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.
A Fuchsia Howard, Joan L Bottorff, Lynda G Balneaves, Charmaine Kim-Sing. BMC Womens Health 2010
21
25

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
25

Impact of risk-reducing salpingo-oophorectomy in premenopausal women.
R F M Vermeulen, M van Beurden, C M Korse, G G Kenter. Climacteric 2017
21
25

Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience.
M G Harmsen, M Arts-de Jong, K Horstik, P Manders, L F A G Massuger, R P M G Hermens, N Hoogerbrugge, G H Woldringh, J A de Hullu. Gynecol Oncol 2016
16
25

Population distribution of lifetime risk of ovarian cancer in the United States.
Celeste Leigh Pearce, Daniel O Stram, Roberta B Ness, Douglas A Stram, Lynda D Roman, Claire Templeman, Alice W Lee, Usha Menon, Peter A Fasching, Jessica N McAlpine,[...]. Cancer Epidemiol Biomarkers Prev 2015
54
12

Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers.
Anouk Pijpe, Peggy Manders, Richard M Brohet, J Margriet Collée, Senno Verhoef, Hans F A Vasen, Nicoline Hoogerbrugge, Christi J van Asperen, Charlotte Dommering, Margreet G E M Ausems,[...]. Breast Cancer Res Treat 2010
50
12




Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
718
12

Central European BRCA2 mutation carriers: birth cohort status correlates with onset of breast cancer.
Muy-Kheng M Tea, Regina Kroiss, Daniela Muhr, Christine Fuerhauser-Rappaport, Peter Oefner, Teresa M Wagner, Christian F Singer. Maturitas 2014
10
12

Epidemiology of breast cancer.
T J Key, P K Verkasalo, E Banks. Lancet Oncol 2001
538
12

A model for estimating ovarian cancer risk: application for preventive oophorectomy.
Vasily Giannakeas, Victoria Sopik, Konstantin Shestopaloff, Javaid Iqbal, Barry Rosen, Mohammad Akbari, Steven A Narod. Gynecol Oncol 2015
6
16

Adult BMI change and risk of Breast Cancer: National Health and Nutrition Examination Survey (NHANES) 2005-2010.
Wambui G Gathirua-Mwangi, Terrell W Zollinger, Mwangi J Murage, Kamnesh R Pradhan, Victoria L Champion. Breast Cancer 2015
16
12


Variation in BRCA1 cancer risks by mutation position.
Deborah Thompson, Douglas Easton. Cancer Epidemiol Biomarkers Prev 2002
148
12


Body weight and risk of breast cancer in BRCA1/2 mutation carriers.
Peggy Manders, Anouk Pijpe, Maartje J Hooning, Irma Kluijt, Hans F A Vasen, Nicoline Hoogerbrugge, Christi J van Asperen, Hanne Meijers-Heijboer, Margreet G E M Ausems, Theo A van Os,[...]. Breast Cancer Res Treat 2011
40
12

Alcohol intake and breast cancer in the European prospective investigation into cancer and nutrition.
Isabelle Romieu, Chiara Scoccianti, Véronique Chajès, Jordi de Batlle, Carine Biessy, Laure Dossus, Laura Baglietto, Françoise Clavel-Chapelon, Kim Overvad, Anja Olsen,[...]. Int J Cancer 2015
53
12

Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation Carriers.
Janet R Vos, Li Hsu, Richard M Brohet, Marian J E Mourits, Jakob de Vries, Kathleen E Malone, Jan C Oosterwijk, Geertruida H de Bock. J Clin Oncol 2015
16
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.